HB 1025 VA

0likes☆Favorite🔕SubscribeShare

Introduced

Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.

• Wendell S. Walker Republican · primary

1. Jan 14, 2026 Prefiled and ordered printed; Offered 01-14-2026 26102452D · lower
2. Jan 14, 2026 Referred to Committee on Health and Human Services · lower
3. Jan 23, 2026 Assigned sub: Health · lower
4. Feb 5, 2026 Fiscal Impact Statement from Department of Planning and Budget (HB1025) · lower
5. Feb 10, 2026 Subcommittee recommends laying on the table (7-Y 1-N) · lower
6. Feb 18, 2026 Left in Committee Health and Human Services · lower

The published texts of this bill as it moves through the legislature. Each links to the official document on the state legislature site. Data from OpenStates.

• Introduced · PDF
• Introduced · HTML